Billiontoone (NASDAQ:BLLN) Trading 6.3% Higher – Still a Buy?

Shares of Billiontoone, Inc. (NASDAQ:BLLN) traded up 6.3% on Monday . The stock traded as high as $94.16 and last traded at $93.13. 56,477 shares traded hands during trading, a decline of 77% from the average session volume of 249,816 shares. The stock had previously closed at $87.57.

Analyst Ratings Changes

BLLN has been the subject of a number of research analyst reports. Stifel Nicolaus initiated coverage on shares of Billiontoone in a research report on Monday, December 1st. They set a “buy” rating and a $145.00 price objective for the company. BTIG Research reaffirmed a “buy” rating and issued a $160.00 price objective on shares of Billiontoone in a research note on Wednesday, December 10th. Wall Street Zen raised Billiontoone to a “hold” rating in a research report on Saturday, November 15th. Piper Sandler reissued an “overweight” rating on shares of Billiontoone in a research report on Wednesday, December 10th. Finally, Guggenheim began coverage on shares of Billiontoone in a research note on Tuesday, January 6th. They issued a “buy” rating and a $120.00 price objective for the company. Six analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $135.29.

Billiontoone Stock Down 1.6%

The stock has a market capitalization of $3.94 billion and a price-to-earnings ratio of 861.80. The firm’s fifty day moving average is $98.12.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings results on Tuesday, December 9th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.06). The company had revenue of $83.52 million during the quarter, compared to analysts’ expectations of $82.86 million.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the company. Green Alpha Advisors LLC acquired a new position in shares of Billiontoone during the fourth quarter worth $436,000. FNY Investment Advisers LLC bought a new stake in Billiontoone in the fourth quarter valued at about $497,000. Massachusetts Financial Services Co. MA acquired a new stake in Billiontoone during the fourth quarter valued at approximately $13,373,000. Finally, Baillie Gifford & Co. bought a new position in Billiontoone during the 4th quarter worth approximately $103,786,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.